SA
Go ProLog In
OPRX
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
14 analysts·Moderate coverage
70
Score
11 Buy (79%)3 Hold (21%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1179%
Hold
321%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$7.00
+34.4%
Consensus
$10.50
+101.5%
Bull
$14.00
+168.7%
12-Month Target Range14 analysts
$7.00$10.50$14.00
Current $5.21Consensus
Current Price
$5.21
Upside to Consensus
$5.29

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+11.25%
EPS+15.27%

Earnings Surprises

Recent Analyst Actions

May 13, 2026UBS
OptimizeRx price target lowered to $10 from $11 at B. Riley
Target:$10.00
+108.6%from $4.79
May 13, 2026Lake Street
OptimizeRx price target lowered to $11 from $20 at Lake Street
Target:$11.00
+126.6%from $4.86
May 13, 2026Stephens
OptimizeRx price target lowered to $7 from $10 at Stephens
Target:$7.00
+10.4%from $6.34
May 13, 2026Stifel Nicolaus
OptimizeRx price target lowered to $14 from $17 at Stifel
Target:$14.00
+120.8%from $6.34
Mar 6, 2026Stifel Nicolaus
OptimizeRX (OPRX) PT Lowered to $17 at Stifel After Flattish Q4 Revenue
Target:$17.00
+150.1%from $6.80
Oct 10, 2025UBS
OptimizeRx price target raised to $23 from $20 at Citizens JMP
Target:$23.00
+25.8%from $18.29
Apr 4, 2024JMP Securities
JMP Securities Starts OptimizeRX (OPRX) at Market Outperform, 'Comprehensive Biopharma Digital Marketing Platform'
Target:$15.00
+34.3%from $11.17

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance